Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 303, Issue 8, 2012, Pages

  Abdala Valencia, Hiam ^a   Berdnikovs, Sergejs ^a   McCary, Christine A ^a   Urick, Daniela ^a   Mahadevia, Riti ^a   Marchese, Michelle E ^a   Swartz, Kelsey ^a   Wright, Lakiea ^a   Mutlu, Gökhan M ^a   Cook Mills, Joan M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

5 hydroxytryptophan metabolites; Endothelial cell; Leukocyte recruitment; Lung; Serotonylation

Indexed keywords

5 HYDROXYTRYPTOPHAN; HOUSE DUST ALLERGEN; INTERLEUKIN 4; OVALBUMIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY DYNAMICS; ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

5-HYDROXYTRYPTOPHAN; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ASTHMA; CELL ADHESION MOLECULES; CELL LINE; CELL MOVEMENT; CHEMOKINES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; HYPERSENSITIVITY; IMMUNOSUPPRESSION; INTERLEUKIN-4; LEUKOCYTES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; PYROGLYPHIDAE; SEROTONIN; SPLEEN;

EID: 84867735503     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00406.2011     Document Type: Article

References (123)

1. Abdala-Valencia H, Cook-Mills JM. VCAM-1 signals activate endothelial cell protein kinase ca via oxidation. J Immunol 177: 6379-6387, 2006.
2. Abdala-Valencia H, Earwood J, Bansal S, Jansen M, Babcock G, Garvy B, Wills-Karp M, Cook-Mills JM. Nonhematopoietic NADPH oxidase regulation of lung eosinophilia and airway hyperresponsiveness in experimentally induced asthma. Am J Physiol Lung Cell Mol Physiol 292: L1111-L1125, 2007.
3. Abdouh M, Albert PR, Drobetsky E, Filep JG, Kouassi E. 5-HT1A-mediated promotion of mitogen-activated T and B cell survival and proliferation is associated with increased translocation of NF-kappaB to the nucleus. Brain Behav Immun 18: 24-34, 2004.
4. Abdouh M, Storring JM, Riad M, Paquette Y, Albert PR, Drobetsky E, Kouassi E. Transcriptional mechanisms for induction of 5-HT1A receptor mRNA and protein in activated B and T lymphocytes. J Biol Chem 276: 4382-4388, 2001.
5. Alberghina D, Amorini AM, Lazzarino G. Modulation of peripheral markers of the serotoninergic system in healthy horses. Res Vet Sci 90: 392-395, 2011.
6. Arita J, Kimura F. In vitro dopamine biosynthesis in the median eminence of rat hypothalamic slices: involvement of voltage-dependent Ca2+ channels. Brain Res 347: 299-305, 1985.
7. Bakker EN, Pistea A, VanBavel E. Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis. J Vasc Res 45: 271-278, 2008.
8. Baumann MH, Williams Z, Zolkowska D, Rothman RB. Serotonin (5-HT) precursor loading with 5-hydroxy-L-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat. Drug Alcohol Depend 114: 147-152, 2011.
9. Berdnikovs S, Abdala-Valencia H, McCary C, Somand M, Cole R, Garcia A, Bryce P, Cook-Mills J. Isoforms of Vitamin E have opposing immunoregulatory funcitons during inflammation by regulating leukocyte recruitment. J Immunol 182: 4395-4405, 2009.
10. Bergamini CM, Griffin M, Pansini FS. Transglutaminase and vascular biology: physiopathologic implications and perspectives for therapeutic interventions. Curr Med Chem 12: 2357-2372, 2005.
11. Berry RB, Hayward LF. Selective augmentation of genioglossus electromyographic activity by L-5-hydroxytryptophan in the rat. Pharmacol Biochem Behav 74: 877-882, 2003.
12. Birdsall TC. 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Altern Med Rev 3: 271-280, 1998.
13. Boehme SA, Lio FM, Sikora L, Pandit TS, Lavrador K, Rao SP, Sriramarao P. Cutting edge: serotonin is a chemotactic factor for eosinophils and functions additively with eotaxin. J Immunol 173: 3599-3603, 2004.
14. Brandt EB, Strait RT, Hershko D, Wang Q, Muntel EE, Scribner TA, Zimmermann N, Finkelman FD, Rothenberg ME. Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest 112: 1666-1677, 2003.
15. Brown ES, Vornik LA, Khan DA, Rush AJ. Bupropion in the treatment of outpatients with asthma and major depressive disorder. Int J Psychiatry Med 37: 23-28, 2007.
16. Carneiro AM, Airey DC, Thompson B, Zhu CB, Lu L, Chesler EJ, Erikson KM, Blakely RD. Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes. Proc Natl Acad Sci USA 106: 2047-2052, 2009.
17. Cazzola I, Matera MG. 5-HT modifiers as a potential treatment of asthma. Trends Pharmacol Sci 21: 13-16, 2000.
18. Chen GL, Vallender EJ, Miller GM. Functional characterization of the human TPH2 5' regulatory region: untranslated region and polymorphisms modulate gene expression in vitro. Hum Genet 122: 645-657, 2008.
19. Chen JJ, Li Z, Pan H, Murphy DL, Tamir H, Koepsell H, Gershon MD. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters. J Neurosci 21: 6348-6361, 2001.
20. Chen YK, Richter HM, 3rd Go VL, Tyce GM. Free and conjugated catecholamines and serotonin in canine thoracic duct lymph: effects of feeding. Am J Physiol Endocrinol Metab 265: E184-E189, 1993.
21. Cheung TK, Lam B, Lam KF, Ip M, Ng C, Kung R, Wong BC. Gastroesophageal reflux disease is associated with poor asthma control, quality of life, and psychological status in Chinese asthma patients. Chest 135: 1181-1185, 2009.
22. Cho S, Duchemin AM, Neff NH, Hadjiconstantinou M. Modulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase after inhibiting monoamine oxidase-A. Eur J Pharmacol 314: 51-59, 1996.
23. Cloez-Tayarani I, Changeux JP. Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol 81: 599-606, 2007.
24. Cook-Mills JM, Gallagher JS, Feldbush TL. Isolation and characterization of high endothelial cell lines derived from mouse lymph nodes in vitro. Cell Develop Biol 32: 167-177, 1996.
25. Cook-Mills JM, Marchese M, Abdala-Valencia H. Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid Redox Signal 15: 1607-1638, 2011.
26. Cook-Mills JM, McCary CA. Isoforms of Vitamin E differentially regulate inflammation. Endocr Metab Immune Disord Drug Targets 10: 348-366, 2010.
27. Cordina M, Fenech AG, Vassallo J, Cacciottolo JM. Anxiety and the management of asthma in an adult outpatient population. Ther Adv Respir Dis 3: 227-233, 2009.
28. Cuffel B, Wamboldt M, Borish L, Kennedy S, Crystal-Peters J. Economic consequences of comorbid depression, anxiety, and allergic rhinitis. Psychosomatics 40: 491-496, 1999.
29. Cyphert JM, Kovarova M, Allen IC, Hartney JM, Murphy DL, Wess J, Koller BH. Cooperation between mast cells and neurons is essential for antigen-mediated bronchoconstriction. J Immunol 182: 7430-7439, 2009.
30. Dai Y, Dudek NL, Patel TB, Muma NA. Transglutaminase-catalyzed transamidation: a novel mechanism for Rac1 activation by 5-hydroxytryptamine2A receptor stimulation. J Pharmacol Exp Ther 326: 153-162, 2008.
31. Deem TL, Abdala-Valencia H, Cook-Mills JM. VCAM-1 activation of PTP1B in endothelial cells. J Immunol 178: 3865-3873, 2007.
32. Delaney C, Gien J, Grover TR, Roe G, Abman SH. Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus. Am J Physiol Lung Cell Mol Physiol 301: L937-L944, 2011.
33. Dempsie Y, MacLean MR. Pulmonary hypertension: therapeutic targets within the serotonin system. Br J Pharmacol 155: 455-462, 2008.
34. DePietro FR, Fernstrom JD. The effect of phenylalanine on DOPA synthesis in PC12 cells. Neurochem Res 23: 1011-1020, 1998.
35. Di Giovanni G, Esposito E, Di Matteo V. Role of serotonin in central dopamine dysfunction. CNS Neurosci Ther 16: 179-194, 2010.
36. Di Marco F, Verga M, Santus P, Giovannelli F, Busatto P, Neri M, Girbino G, Bonini S, Centanni S. Close correlation between anxiety, depression, and asthma control. Respir Med 104: 22-28, 2010.
37. Ding XR, Stier CT Jr, Itskovitz HD. Serotonin and 5-hydroxytrypto-phan on blood pressure and renal blood flow in anesthetized rats. Am J Med Sci 297: 290-293, 1989.
38. Domino EF. Monoamine oxidase substrates and substrate affinity. Schizophr Bull 6: 292-297, 1980.
39. Eddahibi S, Guignabert C, Barlier-Mur AM, Dewachter L, Fadel E, Dartevelle P, Humbert M, Simonneau G, Hanoun N, Saurini F, Hamon M, Adnot S. Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. Circulation 113: 1857-1864, 2006.
40. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-depen-dent T helper cell type 2 responses to inhaled antigen. J Exp Med 196: 1645-1651, 2002.
41. Fattaccini CM, Bolanos-Jimenez F, Gozlan H, Hamon M. Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain. Neuropharmacology 29: 1-8, 1990.
42. Faye C, Inforzato A, Bignon M, Hartmann DJ, Muller L, Ballut L, Olsen BR, Day AJ, Ricard-Blum S. Transglutaminase-2: a new en-dostatin partner in the extracellular matrix of endothelial cells. Biochem J 427: 467-475, 2010.
43. Fisher A, Starr MS. Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain. Brain Res 868: 268-274, 2000.
44. Fitzpatrick PF. Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem 68: 355-381, 1999.
45. Freedman RR. Treatment of menopausal hot flashes with 5-hy-droxytryptophan. Maturitas 65: 383-385, 2010.
46. Fujiwara M, Shibata M, Nomiyama Y, Sugimoto T, Hirata F, Tokuyama T, Senoh S, Hayaishi O. Formation of 5-hydroxykynurenine and 5-hydroxykynurenamine from 5-hydroxytryptophan in rabbit small intestine. Proc Natl Acad Sci USA 76: 1145-1149, 1979.
47. Gardier AM. Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor. Behav Pharmacol 20: 18-32, 2009.
48. Gartside SE, Cowen PJ, Sharp T. Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by micro-dialysis. Neuropharmacology 31: 9-14, 1992.
49. Ghia JE, Li N, Wang H, Collins M, Deng Y, El-Sharkawy RT, Cote F, Mallet J, Khan WI. Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology 137: 1649-1660, 2009.
50. Gijsman HJ, van Gerven JM, de Kam ML, Schoemaker RC, Pieters MS, Weemaes M, de Rijk R, van der Post J, Cohen AF. Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers. J Clin Psychopharmacol 22: 183-189, 2002.
51. Gomes P, Soares-da-Silva P. l-DOPA transport properties in an immortalised cell line of rat capillary cerebral endothelial cells, RBE 4. Brain Res 829: 143-150, 1999.
52. Goshima Y, Nakamura S, Misu Y. L-dopa facilitates the release of endogenous norepinephrine and dopamine via presynaptic beta 1- and beta 2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices. Jpn J Pharmacol 53: 47-56, 1990.
53. Grigoroiu-Serbanescu M, Diaconu CC, Herms S, Bleotu C, Vollmer J, Muhleisen TW, Prelipceanu D, Priebe L, Mihailescu R, Georgescu MJ, Sima D, Grimberg M, Nothen MM, Cichon S. Investigation of the tryptophan hydroxylase 2 gene in bipolar I disorder in the Romanian population. Psychiatr Genet 18: 240-247, 2008.
54. Gruetter CA, Lemke SM, Anestis DK, Szarek JL, Valentovic MA. Potentiation of 5-hydroxytryptamine-induced contraction in rat aorta by chlorpheniramine, citalopram and fluoxetine. Eur J Pharmacol 217: 109-118, 1992.
55. Haleem DJ. Exaggerated feedback control decreases brain serotonin concentration and elicits hyperactivity in a rat model of diet-restriction-induced anorexia nervosa. Appetite 52: 44-50, 2009.
56. Hallstrand TS, Wurfel MM, Lai Y, Ni Z, Gelb MH, Altemeier WA, Beyer RP, Aitken ML, Henderson WR. Transglutaminase 2, a novel regulator of eicosanoid production in asthma revealed by genome-wide expression profiling of distinct asthma phenotypes. PLoS ONE 5: e8583, 2010.
57. Hennig J, Reuter M, Netter P, Burk C, Landt O. Two types of aggression are differentially related to serotonergic activity and the A779C TPH polymorphism. Behav Neurosci 119: 16-25, 2005.
58. Hranilovic D, Blazevic S, Ivica N, Cicin-Sain L, Oreskovic D. The effects of the perinatal treatment with 5-hydroxytryptophan or tranylcy-promine on the peripheral and central serotonin homeostasis in adult rats. Neurochem Int 59: 202-207, 2011.
59. Izikki M, Hanoun N, Marcos E, Savale L, Barlier-Mur AM, Saurini F, Eddahibi S, Hamon M, Adnot S. Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice. Am J Physiol Lung Cell Mol Physiol 293: L1045-L1052, 2007.
60. Jacobs GE, Kamerling IM, de Kam ML, Derijk RH, van Pelt J, Zitman FG, van Gerven JM. Enhanced tolerability of the 5-hy-droxytryptophane challenge test combined with granisetron. J Psycho-pharmacol 24: 65-72, 2010.
61. Jernej B, Stefulj J, Hranilovic D, Balija M, Skavic J, Kubat M. Intronic polymorphism of tryptophan hydroxylase and serotonin transporter: indication for combined effect in predisposition to suicide. J Neural Transm 111: 733-738, 2004.
62. Kawahara K, Hashiguchi T, Kikuchi K, Tancharoen S, Miura N, Ito T, Oyama Y, Nawa Y, Biswas KK, Meng X, Morimoto Y, Shrestha B, Sameshima H, Maruyama I. Induction of high mobility group box 1 release from serotonin-stimulated human umbilical vein endothelial cells. Int J Mol Med 22: 639-644, 2008.
63. Keshavan P, Deem TL, Schwemberger SJ, Babcock GF, Cook-Mills JM, Zucker SD. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J Immunol 174: 3709-3718, 2005.
64. Kim DY, Park BS, Hong GU, Lee BJ, Park JW, Kim SY, Ro JY. Anti-inflammatory effects of the R2 peptide, an inhibitor of transglu-taminase 2, in a mouse model of allergic asthma, induced by ovalbumin. Br J Pharmacol 162: 210-225, 2011.
65. Kim Y, Eom S, Kim K, Lee YS, Choe J, Hahn JH, Lee H, Kim YM, Ha KS, Ro JY, Jeoung D. Transglutaminase II interacts with rac1, regulates production of reactive oxygen species, expression of snail, secretion of Th2 cytokines and mediates in vitro and in vivo allergic inflammation. Mol Immunol 47: 1010-1022, 2010.
66. Kushnir-Sukhov NM, Gilfillan AM, Coleman JW, Brown JM, Bru-ening S, Toth M, Metcalfe DD. 5-hydroxytryptamine induces mast cell adhesion and migration. J Immunol 177: 6422-6432, 2006.
67. Laengle UW, Markstein R, Pralet D, Seewald W, Roman D. Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells. Exp Eye Res 83: 1335-1339, 2006.
68. Laengle UW, Markstein R, Pralet D, Seewald W, Roman D. Effects of latanoprost, timolol and GLC756, a novel dopamine D(2) agonist and D(1) antagonist on LTC(4) release after rat mast cell activation. Clin Experiment Ophthalmol 35: 645-650, 2007.
69. Lechin F, van der Dijs B, Orozco B, Jara H, Rada I, Lechin ME, Lechin AE. Neuropharmacologic treatment of bronchial asthma with the antidepressant tianeptine: a double-blind, crossover placebo-controlled study. Clin Pharmacol Ther 64: 223-232, 1998.
70. Lechin F, van der Dijs B, Orozco B, Jara H, Rada I, Lechin ME, Lechin AE. The serotonin uptake-enhancing drug tianeptine suppresses asthmatic symptoms in children: a double-blind, crossover, placebo-controlled study. J Clin Pharmacol 38: 918-925, 1998.
71. Lechin F, van der Dijs B, Orozco B, Lechin M, Lechin AE. Increased levels of free serotonin in plasma of symptomatic asthmatic patients. Ann Allergy Asthma Immunol 77: 245-253, 1996.
72. Leon-Ponte M, Ahern GP, O'Connell PJ. Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood 109: 3139-3146, 2007.
73. Levite M. Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. Curr Opin Pharmacol 8: 460-471, 2008.
74. Lin YM, Chao SC, Chen TM, Lai TJ, Chen JS, Sun HS. Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han Chinese. Arch Gen Psychiatry 64: 1015-1024, 2007.
75. Liu Y, Wei L, Laskin DL, Fanburg BL. Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 44: 548-555, 2011.
76. Lowe SL, Yeo KP, Teng L, Soon DK, Pan A, Wise SD, Peck RW. L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI. Psychoneuroendocrinology 31: 473-484, 2006.
77. Lynn-Bullock CP, Welshhans K, Pallas SL, Katz PS. The effect of oral 5-HTP administration on 5-HTP and 5-HT immunoreactivity in monoaminergic brain regions of rats. J Chem Neuroanat 27: 129-138, 2004.
78. MaassenVanDenBrink A, Centurion D, Villalon CM. Crosstalk of vascular 5-HT1 receptors with other receptors: clinical implications. Neuropharmacology 55: 986-993, 2008.
79. MacLean MR. Pulmonary hypertension and the serotonin hypothesis: where are we now? Int J Clin Pract Suppl 156: 27-31, 2007.
80. MacLean MR, Dempsie Y. Serotonin and pulmonary hypertension- from bench to bedside? Curr Opin Pharmacol 9: 281-286, 2009.
81. Maclean MR, Dempsie Y. The serotonin hypothesis of pulmonary hypertension revisited. Adv Exp Med Biol 661: 309-322, 2010.
82. Manuck SB, Flory JD, Ferrell RE, Dent KM, Mann JJ, Muldoon MF. Aggression and anger-related traits associated with a polymorphism of the tryptophan hydroxylase gene. Biol Psychiatry 45: 603-614, 1999.
83. Mason SS, Baker KB, Davis KW, Pogorelov VM, Malbari MM, Ritter R, Wray SP, Gerhardt B, Lanthorn TH, Savelieva KV. Differential sensitivity to SSRI and tricyclic antidepressants in juvenile and adult mice of three strains. Eur J Pharmacol 602: 306-315, 2009.
84. Matheny HE, Deem TL, Cook-Mills JM. Lymphocyte migration through monolayers of endothelial cell lines involves VCAM-1 signaling via endothelial cell NADPH oxidase. J Immunol 164: 6550-6559, 2000.
85. Menard G, Turmel V, Bissonnette EY. Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2. Clin Exp Immunol 150: 340-348, 2007.
86. Mohan K, Pinto D, Issekutz TB. Identification of tissue transglutaminase as a novel molecule involved in human CD8 + T cell transendothe-lial migration. J Immunol 171: 3179-3186, 2003.
87. Morecroft I, Dempsie Y, Bader M, Walther DJ, Kotnik K, Loughlin L, Nilsen M, MacLean MR. Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension. Hypertension 49: 232-236, 2007.
88. Muller T, Durk T, Blumenthal B, Grimm M, Cicko S, Panther E, Sorichter S, Herouy Y, Di Virgilio F, Ferrari D, Norgauer J, Idzko M. 5-hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo. PLoS ONE 4: e6453, 2009.
89. Nakagome K, Imamura M, Okada H, Kawahata K, Inoue T, Hashimoto K, Harada H, Higashi T, Takagi R, Nakano K, Hagiwara K, Kanazawa M, Dohi M, Nagata M, Matsushita S. Dopamine D1-like receptor antagonist attenuates Th17-mediated immune response and ovalbumin antigen-induced neutrophilic airway inflammation. J Immunol 186: 5975-5982, 2011.
90. Neal KB, Parry LJ, Bornstein JC. Strain-specific genetics, anatomy and function of enteric neural serotonergic pathways in inbred mice. J Physiol 587: 567-586, 2009.
91. Ortiz J, Mariscot C, Alvarez E, Artigas F. Effects of the antidepressant drug tianeptine on plasma and platelet serotonin of depressive patients and healthy controls. J Affect Disord 29: 227-234, 1993.
92. Ortiz J, Mocaer E, Artigas F. Effects of the antidepressant drug tianeptine on plasma and platelet serotonin concentrations in the rat. Eur J Pharmacol 199: 335-339, 1991.
93. Park D, Choi SS, Ha KS. Transglutaminase 2: a multi-functional protein in multiple subcellular compartments. Amino Acids 39: 619-631, 2010.
94. Pero RS, Borchers MT, Spicher K, Ochkur SI, Sikora L, Rao SP, Abdala-Valencia H, O'Neill KR, Shen H, McGarry MP, Lee NA, Cook-Mills JM, Sriramarao P, Simon MI, Birnbaumer L, Lee JJ. Galphai2-mediated signaling events in the endothelium are involved in controlling leukocyte extravasation. Proc Natl Acad Sci USA 104: 4371-4376, 2007.
95. Perry KW, Fuller RW. Extracellular 5-hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus L-5-hydroxytryptophan. J Pharm Pharmacol 45: 759-761, 1993.
96. Qureshi MH, Cook-Mills J, Doherty DE, Garvy BA. TNF-alpha-dependent ICAM-1- and VCAM-1-mediated inflammatory responses are delayed in neonatal mice infected with Pneumocystis carinii. J Immunol 171: 4700-4707, 2003.
97. Rotondo A, Schuebel K, Bergen A, Aragon R, Virkkunen M, Lin-noila M, Goldman D, Nielsen D. Identification of four variants in the tryptophan hydroxylase promoter and association to behavior. Mol Psychiatry 4: 360-368, 1999.
98. Rujescu D, Giegling I, Bondy B, Gietl A, Zill P, Moller HJ. Association of anger-related traits with SNPs in the TPH gene. Mol Psychiatry 7: 1023-1029, 2002.
99. Sanger GJ, Banner SE, Smith MI, Wardle KA. SB-207266: 5-HT4 receptor antagonism in human isolated gut and prevention of 5-HT-evoked sensitization of peristalsis and increased defaecation in animal models. Neurogastroenterol Motil 10: 271-279, 1998.
100. Sansone RA, Sansone LA. Asthma: wheezing, woes, and worries. Psychiatry 5: 48-52, 2008.
101. Schruers K, van Diest R, Overbeek T, Griez E. Acute L-5-hy-droxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patients. Psychiatry Res 113: 237-243, 2002.
102. Serretti A, Artioli P. From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes. Psychopharmacology (Berl) 174: 490-503, 2004.
103. Smarius LJ, Jacobs GE, Hoeberechts-Lefrandt DH, de Kam ML, van der Post JP, de Rijk R, van Pelt J, Schoemaker RC, Zitman FG, van Gerven JM, Gijsman HJ. Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa. J Psychopharmacol 22: 426-433, 2008.
104. Solberg LC, Valdar W, Gauguier D, Nunez G, Taylor A, Burnett S, Arboledas-Hita C, Hernandez-Pliego P, Davidson S, Burns P, Bhattacharya S, Hough T, Higgs D, Klenerman P, Cookson WO, Zhang Y, Deacon RM, Rawlins JN, Mott R, Flint J. A protocol for high-throughput phenotyping, suitable for quantitative trait analysis in mice. Mamm Genome 17: 129-146, 2006.
105. Stone RA, Worsdell YM, Fuller RW, Barnes PJ. Effects of 5-hydroxy-tryptamine and 5-hydroxytryptophan infusion on the human cough reflex. J Appl Physiol 74: 396-401, 1993.
106. Strine TW, Mokdad AH, Balluz LS, Gonzalez O, Crider R, Berry JT, Kroenke K. Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System. Psychiatr Serv 59: 1383-1390, 2008.
107. Tachimoto H, Burdick MM, Hudson SA, Kikuchi M, Konstantopou-los K, Bochner BS. CCR3-active chemokines promote rapid detachment of eosinophils from VCAM-1 in vitro. J Immunol 165: 2748-2754, 2000.
108. Tenner K, Qadri F, Bert B, Voigt JP, Bader M. The mTPH2 C1473G single nucleotide polymorphism is not responsible for behavioural differences between mouse strains. Neurosci Lett 431: 21-25, 2008.
109. Thomas M. Pharmacological targets for pulmonary vascular disease: vasodilation versus anti-remodelling. Adv Exp Med Biol 661: 475-490, 2010.
110. Tudor KSRS, Hess KL, Cook-Mills JM. Cytokines modulate endothelial cell intracellular signal transduction required for VCAM-1-dependent lymphocyte transendothelial migration. Cytokine 15: 196-211, 2001.
111. Tzvetkov MV, Brockmoller J, Roots I, Kirchheiner J. Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment. Pharmacogenet Genomics 18: 495-506, 2008.
112. Van Lieshout RJ, Bienenstock J, MacQueen GM. A review of candidate pathways underlying the association between asthma and major depressive disorder. Psychosom Med 71: 187-195, 2009.
113. Vanoirbeek JA, Rinaldi M, De Vooght V, Haenen S, Bobic S, Gayan-Ramirez G, Hoet PH, Verbeken E, Decramer M, Nemery B, Janssens W. Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol 42: 96-104, 2010.
114. Veenstra-VanderWeele J, Anderson GM, Cook EH Jr. Pharmacogenetics and the serotonin system: initial studies and future directions. Eur J Pharmacol 410: 165-181, 2000.
115. Vega Lde L, Munoz E, Calzado MA, Lieb K, Candelario-Jalil E, Gschaidmeir H, Farber L, Mueller W, Stratz T, Fiebich BL. The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway. Biochem Pharmacol 70: 369-380, 2005.
116. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, Bader M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299: 76, 2003.
117. Wanstall JC, Fiore SA, Gambino A, Chess-Williams R. Potentiation of 5-hydroxytryptamine (5-HT) responses by a 5-HT uptake inhibitor in pulmonary and systemic vessels: effects of exposing rats to hypoxia. Naunyn Schmiedebergs Arch Pharmacol 368: 520-527, 2003.
118. Watts SW, Davis RP. 5-Hydroxtryptamine Receptors in Systemic Hypertension: An Arterial Focus. Cardiovasc Ther 29: 54-67, 2010.
119. Watts SW, Priestley JR, Thompson JM. Serotonylation of vascular proteins important to contraction. PLoS ONE 4: e5682, 2009.
120. Wrona MZ, Dryhurst G. A putative metabolite of serotonin, tryptam-ine-4,5-dione, is an irreversible inhibitor of tryptophan hydroxylase: possible relevance to the serotonergic neurotoxicity of methamphet-amine. Chem Res Toxicol 14: 1184-1192, 2001.
121. Xu H, Zhang GX, Ciric B, Rostami A. IDO: a double-edged sword for T(H)1/T(H)2 regulation. Immunol Lett 121: 1-6, 2008.
122. Yin J, Albert RH, Tretiakova AP, Jameson BA. 5-HT(1B) receptors play a prominent role in the proliferation of T-lymphocytes. J Neuroim-munol 181: 68-81, 2006.
123. Zabel M. Studies on in vitro effect of serotonin on calcitonin secretion by rat thyroid C cells. Histochemistry 83: 71-75, 1985.